BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2658742)

  • 1. Molecular pathogenesis of Ph-positive leukemias.
    Clark SS; Crist WM; Witte ON
    Annu Rev Med; 1989; 40():113-22. PubMed ID: 2658742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular biology of chronic myeloid leukemia].
    Hellmann A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncogenes and malignant hemopathies].
    Pogliani EM; Bregani ER; Corneo G
    Recenti Prog Med; 1989 Oct; 80(10):526-30. PubMed ID: 2690219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
    Becher R; Kloke O
    Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
    Nishigaki H; Misawa S; Inazawa J; Abe T
    Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel five-way chromosomal translocation observed in chronic myelogenous leukemia.
    Ikuta K; Torimoto Y; Jimbo J; Inamura J; Hosoki T; Shindo M; Sato K; Takahashi H; Kohgo Y
    Cancer Genet Cytogenet; 2008 May; 183(1):69-71. PubMed ID: 18474301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant forms of Philadelphia translocation in two patients with chronic myeloid leukemia.
    Valent A; Zámecníková A; Karlic H; Nowotny H; Krizan P
    Neoplasma; 1996; 43(4):239-44. PubMed ID: 8931748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia as gene activation model in oncology minireview.
    Zámecníková A
    Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
    Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of fluorescence in situ hybridization technique in diagnosis of variant Ph chromosome translocation and Ph-negative chronic myelocytic leukemia].
    Jing Y; Jiang F; Lin S; Wang FT; Fang MY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):563-6. PubMed ID: 20931538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.